Literature DB >> 8449191

An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man.

M Karamanoglu1, M F O'Rourke, A P Avolio, R P Kelly.   

Abstract

Amplification of the pressure pulse between central and peripheral arteries renders pressure values in the upper limb an inaccurate measure of ascending aortic (AA) pressure. Accuracy could be improved by allowance for such amplification. Transfer functions (TF) for pressures between AA and brachial artery (BA):(BATF) and between AA and radial artery (RA):(RATF) were derived from high-fidelity pressure recordings obtained at cardiac catheterization in 14 patients under control conditions, and after sublingual nitroglycerine 0.3 mg. There was no significant difference in BATF under control conditions and with nitroglycerine; hence results were pooled. Control and nitroglycerine results were also pooled to obtain a single RATF. BATF and RATF moduli peaked at 5 Hz and 4 Hz, reaching 2.5 and 2.8 times the value at zero frequency respectively. Frequency-dependent changes in modulus and phase of BATF and RATF were attributable to wave travel and reflection in the upper limb. BATF and RATF were compared to published transfer functions and those derived from analysis of aortic and brachial or radial pressure waves in previous publications. Results were similar. Our BATF and RATF were used to synthesize AA pressure waves from published peripheral pulses. Correspondence was close, especially for systolic pressure which differed by 2.4 +/- 1.0 (mean +/- SEM) mmHg, whereas recorded systolic pressure differed by 20.4 +/- 2.6 (mean +/- SEM) mmHg between central and peripheral sites. Results indicate that in adult humans a single generalized TF can be used with acceptable accuracy to determine central from peripheral pressure under different conditions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8449191     DOI: 10.1093/eurheartj/14.2.160

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  142 in total

1.  Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man.

Authors:  I B Wilkinson; H MacCallum; P C Hupperetz; C J van Thoor ; J R Cockcroft; D J Webb
Journal:  J Physiol       Date:  2001-02-01       Impact factor: 5.182

2.  The influence of heart rate on augmentation index and central arterial pressure in humans.

Authors:  I B Wilkinson; H MacCallum; L Flint; J R Cockcroft; D E Newby; D J Webb
Journal:  J Physiol       Date:  2000-05-15       Impact factor: 5.182

3.  Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo.

Authors:  Ian B Wilkinson; Helen MacCallum; John R Cockcroft; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

Review 4.  Pulse wave analysis.

Authors:  M F O'Rourke; A Pauca; X J Jiang
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

Review 5.  Noninvasive studies of central aortic pressure.

Authors:  Michael F O'Rourke; Audrey Adji
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 6.  Meta-analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation index.

Authors:  Charlotte H Manisty; Alun D Hughes
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

Review 7.  Noninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform?

Authors:  Matthew R Nelson; Jan Stepanek; Michael Cevette; Michael Covalciuc; R Todd Hurst; A Jamil Tajik
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

Review 8.  Continuous and less invasive central hemodynamic monitoring by blood pressure waveform analysis.

Authors:  Ramakrishna Mukkamala; Da Xu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-09       Impact factor: 4.733

9.  The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial.

Authors:  Whitney Wharton; James H Stein; Claudia Korcarz; Jane Sachs; Sandra R Olson; Henrik Zetterberg; Maritza Dowling; Shuyun Ye; Carey E Gleason; Gail Underbakke; Laura E Jacobson; Sterling C Johnson; Mark A Sager; Sanjay Asthana; Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

10.  As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout.

Authors:  A-K Tausche; M Christoph; M Forkmann; U Richter; S Kopprasch; C Bielitz; M Aringer; C Wunderlich
Journal:  Rheumatol Int       Date:  2013-09-12       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.